失眠认知行为疗法对退伍军人酒精治疗结局的影响:随机临床试验
该随机临床试验纳入67名正在接受酒精使用障碍治疗的退伍军人,比较5次每周失眠认知行为疗法(CBT-I)与单次睡眠卫生教育的效果。CBT-I组在治疗后及随访时失眠严重程度和睡眠效率改善更明显,随访时酒精相关问题减少更多,且该效应由治疗后失眠改善中介;但两组在戒酒或重度饮酒频率上无差异。
要点
- CBT-I较睡眠卫生教育更显著降低失眠严重程度并改善睡眠效率。
- CBT-I组随访时酒精相关问题减少更多,且由失眠改善中介。
- 两组在戒酒率或重度饮酒频率上未见差异。
核心结论
- 在早期酒精使用障碍治疗的退伍军人中,CBT-I在减少失眠症状和酒精相关问题方面优于睡眠卫生教育,但对重度饮酒频率无影响。
- CBT-I应被视为失眠的一线治疗,无论是否已戒酒。
研究设计与样本
- 随机临床试验,2019至2022年通过退伍军人健康管理局医院成瘾治疗项目招募67名正在治疗酒精使用障碍且符合失眠障碍标准的退伍军人。
- 参与者随机接受5次每周CBT-I或单次睡眠卫生教育(对照),在治疗后和6周随访时评估。
主要发现
- CBT-I组较对照组在治疗后失眠严重程度下降更多(组×时间交互:-3.70;95%CI,-6.79至-0.61),随访时亦更多(-3.34;95%CI,-6.46至-0.23)。
- CBT-I组睡眠效率改善更大(治疗后:8.31;95%CI,1.35至15.26;随访:18.03;95%CI,10.46至25.60)。
- CBT-I组随访时酒精相关问题减少更多(组×时间交互:-0.84;95%CI,-1.66至-0.02),且该效应由治疗后失眠严重程度变化中介。
- 两组在戒酒或重度饮酒频率上无组间差异。
关键数值与推荐
- 失眠严重程度采用失眠严重程度指数评估;饮酒频率采用时间线回溯法(女性4杯、男性≥5杯为重度饮酒);酒精相关问题采用问题简表。
- 共67名退伍军人,平均(SD)年龄46.3(11.8)岁;61名(91%)男性,6名(9%)女性;CBT-I组32人,睡眠卫生组35人;59人(88%)提供治疗后或随访数据。
临床怎么用
- 对于正在治疗酒精使用障碍且合并失眠的患者,可早期提供CBT-I而不必等待戒酒成功。
- CBT-I可能通过改善失眠来减少酒精相关问题,但不应期望其直接降低重度饮酒频率。
局限性
- 样本量较小(67人),且以男性退伍军人为主(91%),外推需谨慎。
- 随访时间较短(6周),长期效果未评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Three of 4 adults in treatment for alcohol use disorder (AUD) report symptoms of insomnia. Yet the first-line treatment for insomnia (cognitive behavioral therapy for insomnia, CBT-I) is often delayed until abstinence is established. OBJECTIVE: To test the feasibility, acceptability, and preliminary efficacy of CBT-I among veterans early in their AUD treatment and to examine improvement in insomnia as a mechanism for improvement in alcohol use outcomes. DESIGN, SETTING, AND PARTICIPANTS: For this randomized clinical trial, participants were recruited through the Addictions Treatment Program at a Veterans Health Administration hospital between 2019 and 2022. Patients in treatment for AUD were eligible if they met criteria for insomnia disorder and reported alcohol use in the past 2 months at baseline. Follow-up visits occurred posttreatment and at 6 weeks. INTERVENTIONS: Participants were randomly assigned to receive 5 weekly sessions of CBT-I or a single session about sleep hygiene (control). Participants were asked to complete sleep diaries for 7 days at each assessment. MAIN OUTCOMES AND MEASURES: Primary outcomes included posttreatment insomnia severity (assessed using the Insomnia Severity Index) and follow-up frequency of any drinking and heavy drinking (4 drinks for women, ≥5 drinks for men; number of days via Timeline Followback) and alcohol-related problems (Short Inventory of Problems). Posttreatment insomnia severity was tested as a mediator of CBT-I effects on alcohol use outcomes at the 6-week follow-up. RESULTS: The study cohort included 67 veterans with a mean (SD) age of 46.3 years (11.8); 61 (91%) were male and 6 (9%) female. The CBT-I group included 32 participants, and the sleep hygiene control group 35 participants. Of those randomized, 59 (88%) provided posttreatment or follow-up data (31 CBT-I, 28 sleep hygiene). Relative to sleep hygiene, CBT-I participants reported greater decreases in insomnia severity at posttreatment (group × time interaction: -3.70; 95% CI, -6.79 to -0.61) and follow-up (-3.34; 95% CI, -6.46 to -0.23) and greater improvements in sleep efficiency (posttreatment, 8.31; 95% CI, 1.35 to 15.26; follow-up, 18.03; 95% CI, 10.46 to 25.60). They also reported greater decreases in alcohol problems at follow-up (group × time interaction: -0.84; 95% CI, -1.66 to -0.02), and this effect was mediated by posttreatment change in insomnia severity. No group differences emerged for abstinence or heavy-drinking frequency. CONCLUSIONS AND RELEVANCE: In this randomized clinical trial, CBT-I outperformed sleep hygiene in reducing insomnia symptoms and alcohol-related problems over time but had no effect on frequency of heavy drinking. CBT-I should be considered a first-line treatment for insomnia, regardless of abstinence. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03806491.
引用
- Miller MB, Carpenter RW, Freeman LK, et al. Effect of Cognitive Behavioral Therapy for Insomnia on Alcohol Treatment Outcomes Among US Veterans: A Randomized Clinical Trial. JAMA Psychiatry. 2023. PMID: 37342036. doi:10.1001/jamapsychiatry.2023.1971
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。